Navigation Links
The Avanta Soft Skeletal Hand Implant System

ProductsThe Avanta Soft Skeletal Hand Implant System
Company Small Bone Innovations, Inc.
Item The Avanta Soft Skeletal Hand Implant System
Features 
  • The Avanta MCP and PIP Soft Skeletal Implants constructed of Silflex II advanced elastomer, offer post-surgical results unavailable in any other finger joint implants.
  • The only silicone product line which accommodates the specific, unique biomechanics and anatomy of the MCP and PIP joints.
  • Each product has supporting instruments consisting of color coded broaches, trials, and package labeling for convenient accurate identification.
  • Description Arthritis of the hand can make simple motions such as gripping an object or turning a key painful, if not impossible. The Avanta Soft Skeletal Hand Implants can help alleviate the disabling effects of this disease. By incorporating advanced materials, extensive clinical experience, and joint-specific design features these implants offer todays hand surgeon advantages not currently available in other finger joints. Avanta also offers a Preflex™ Finger Joint Implant - angled at 30-degress to anatomically simulate the MCP joint at rest.
    Info Small Bone Innovations, Inc.
    Customer Service: (800) 778-8837
    Web site: http://www.totalsmallbone.com/

    Related medicine products :

    1. Avanta Trapezio-Metacarpal Prosthesis
    2. Avanta Total Wrist
    3. Skeletal Traction Pins, Full Pin with Cove Point
    4. Skeletal Traction Pins, Half Pin with Cove Point
    5. Meridional Implant (106 Style)
    6. Meridional Implant (103 Style)
    7. Meridional Implant (112 Style)
    8. Cylindrical Sponge Implants - 3.0 x 80 mm
    9. Olk Design Sponge Implants - 5.0 x 2.5 x 80 mm
    10. Olk Design Sponge Implants - 7.5 x 2.75 x 80 mm
    11. Cylindrical Sponge Implants - 4.0 x 80 mm
    Four way compression with five contact closures...
    Applies pressure on scalp to stretch it before surgery...
    Facial Mask...
    Facial Chin and Neck Support...
    Medicine Products:
    (Date:6/25/2017)... ... ... Republicans in the United States Senate on Thursday released their version of ... differs significantly from the American Health Care Act, which the House passed in May, ... will have to take up the Senate version as-is, if it passes. , The ...
    (Date:6/25/2017)... ... 25, 2017 , ... CareSet Labs released the Root NPI Graph today at ... new, greatly improved version of the Doctor Referral teaming dataset commonly available from Medicare. ... subsequently called the the “Doctor Referral Dataset” as released by Medicare and “DocGraph” as ...
    (Date:6/25/2017)... , ... June 25, 2017 , ... June is Men’s Health Month and ... most common cancer among men in the U.S. and the third most common cause of ... estimated that one man in seven will be diagnosed with prostate cancer during his lifetime. ...
    (Date:6/24/2017)... Erie, PA (PRWEB) , ... June 24, 2017 ... ... was held in Erie, PA at the Sheraton Erie Bayfront and Erie Convention ... hands-on evidence based medicine experience, exhibits, a student quiz bowl, award and scholarship ...
    (Date:6/24/2017)... ... ... The weather is heating up and the days are getting longer, providing the ... the summer months provide more than warmer temperatures that are perfect for BBQ’s and ... from direct exposure to the sun. When it comes to the security of homes ...
    Breaking Medicine News(10 mins):
    (Date:6/16/2017)... , June 16, 2017  Exactly 50 years ago ... off what later became known as the San Francisco "Summer ... ) is unveiling two radical innovations in strategic market research ... This announcement marks the beginning of Northern Light,s "Summer of ... ...
    (Date:6/14/2017)... 2017  In 2016, Embodied Labs took ... competition and came away with $25,000 in seed-fund investment. ... Forbes as "entering the life of another" and by ... "empathy to medical professionals in an entirely new dimension." ... a finalist for the Department of Education,s EdSimChallenge, where ...
    (Date:6/11/2017)... 10, 2017  Eli Lilly and Company (NYSE: ... 3 studies of galcanezumab, an investigational treatment for the ... on several key secondary endpoints for galcanezumab compared to ... studies (EVOLVE-1, EVOLVE-2 and REGAIN) will be presented today ... in Boston . ...
    Breaking Medicine Technology: